Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
FDA's update on troubled heart devices | Redo TAVR | The high costs of semaglutide | More from the last week
Saturday, September 9, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

FDA shares update on heart devices linked to multiple recalls and patient deaths

The devices, designed to provide temporary support to a patient's left ventricle, have been associated with a long list of issues in recent months. 

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

FDA shares update on heart devices linked to multiple recalls and patient deaths

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
The devices, designed to provide temporary support to a patient's left ventricle, have been associated with a long list of issues in recent months. 
READ MORE >

Confirmed: Redo TAVR with balloon-expandable valves is safe and effective

The study, based on STS/ACC registry data, represents a collaboration between several leading TAVR specialists. 

READ MORE >
With advances and increased experience in the percutaneous coronary intervention (PCI), same-day discharge (SDD) has become increasingly commonplace, but patient selection is key. Antithrombotic therapy may not be necessary for certain transcatheter aortic valve replacement (TAVR) patients, according to a new analysis published in JACC: Cardiovascular Interventions.
Share on Twitter Share on Facebook Share on Linkedin

Confirmed: Redo TAVR with balloon-expandable valves is safe and effective

Share on Twitter Share on Facebook Share on Linkedin
With advances and increased experience in the percutaneous coronary intervention (PCI), same-day discharge (SDD) has become increasingly commonplace, but patient selection is key. Antithrombotic therapy may not be necessary for certain transcatheter aortic valve replacement (TAVR) patients, according to a new analysis published in JACC: Cardiovascular Interventions.
The study, based on STS/ACC registry data, represents a collaboration between several leading TAVR specialists. 
READ MORE >

Private equity-backed cardiology management group acquires another Florida practice, its 5th of 2023

The Orlando-based management group has expanded its footprint in the Sunshine State yet again.

READ MORE >
Handshake
Share on Twitter Share on Facebook Share on Linkedin

Private equity-backed cardiology management group acquires another Florida practice, its 5th of 2023

Share on Twitter Share on Facebook Share on Linkedin
Handshake
The Orlando-based management group has expanded its footprint in the Sunshine State yet again.
READ MORE >

Weight loss drug semaglutide linked to better heart health, but high costs may limit its impact

It could cost more than $1 million just to avoid a single heart attack, stroke or cardiovascular death, researchers wrote. 

READ MORE >
money maze payment reimbursement
Share on Twitter Share on Facebook Share on Linkedin

Weight loss drug semaglutide linked to better heart health, but high costs may limit its impact

Share on Twitter Share on Facebook Share on Linkedin
money maze payment reimbursement
It could cost more than $1 million just to avoid a single heart attack, stroke or cardiovascular death, researchers wrote. 
READ MORE >

Delirium after TAVR: A common side effect linked to increased mortality

Temporary changes in cognition, including disorganized thinking, are seen in a significant number of patients following transcatheter aortic valve replacement. 

READ MORE >
stroke brain dementia alzheimer's puzzle mental health
Share on Twitter Share on Facebook Share on Linkedin

Delirium after TAVR: A common side effect linked to increased mortality

Share on Twitter Share on Facebook Share on Linkedin
stroke brain dementia alzheimer's puzzle mental health
Temporary changes in cognition, including disorganized thinking, are seen in a significant number of patients following transcatheter aortic valve replacement. 
READ MORE >

Multimodality imaging helps cardiologists manage heart failure patients—with an assist from AI

Purvi Parwani, MD, discussed the trend toward multimodality imaging for heart failure management. All modalities have their own weaknesses, she explained. 

READ MORE >
Purvi Parwani, MD, director of echocardiography, Loma Linda University Medical Center, explains the trend where heart failure imaging guidelines are driving a rising use of mixed multimodality imaging. #ASE #ASE2023
Share on Twitter Share on Facebook Share on Linkedin

Multimodality imaging helps cardiologists manage heart failure patients—with an assist from AI

Share on Twitter Share on Facebook Share on Linkedin
Purvi Parwani, MD, director of echocardiography, Loma Linda University Medical Center, explains the trend where heart failure imaging guidelines are driving a rising use of mixed multimodality imaging. #ASE #ASE2023
Purvi Parwani, MD, discussed the trend toward multimodality imaging for heart failure management. All modalities have their own weaknesses, she explained. 
READ MORE >

Boston Scientific gains FDA approval for Watchman FLX Pro LAAC device

This represents the latest iteration of the Watchman technology, which was first approved by the FDA back in 2020. 

READ MORE >
Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for its Watchman FLX Pro left atrial appendage closure (LAAC) device
Share on Twitter Share on Facebook Share on Linkedin

Boston Scientific gains FDA approval for Watchman FLX Pro LAAC device

Share on Twitter Share on Facebook Share on Linkedin
Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for its Watchman FLX Pro left atrial appendage closure (LAAC) device
This represents the latest iteration of the Watchman technology, which was first approved by the FDA back in 2020. 
READ MORE >

Bleeding events after TAVR: An updated look at a serious side effect

Researchers explored data from more than 2,300 patients, categorizing all bleeding events based on updated VARC-3 definitions. The team's final analysis was published in JACC: Cardiovascular Interventions.

READ MORE >
The Society of Cardiovascular Computed Tomography developed and published the new document to help educate healthcare providers who regularly treat acute chest pain in the emergency department (ED). 
Share on Twitter Share on Facebook Share on Linkedin

Bleeding events after TAVR: An updated look at a serious side effect

Share on Twitter Share on Facebook Share on Linkedin
The Society of Cardiovascular Computed Tomography developed and published the new document to help educate healthcare providers who regularly treat acute chest pain in the emergency department (ED). 
Researchers explored data from more than 2,300 patients, categorizing all bleeding events based on updated VARC-3 definitions. The team's final analysis was published in JACC: Cardiovascular Interventions.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup